Lupin Limited has informed the Exchange regarding a press release dated May 19, 2026, titled "Lupin Makes its Debut in Dow Jones Best-in-Class Indices 2026".
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lupin Limited has been included for the first time in the Dow Jones Best-in-Class (DJBIC) Indices, appearing in both the World Index and the Emerging Markets Index. This recognition is based on strong ESG (Environmental, Social, Governance) performance assessed through S&P Global Corporate Sustainability Assessment. Lupin was previously ranked among the top 1% globally with an industry-leading score of 91 out of 100 in the S&P Global CSA 2025. The DJBIC indices track the top 10% of the largest sustainable companies globally and in emerging markets respectively. This achievement reinforces Lupin's position as a sustainability leader among global pharmaceutical companies.
This recognition enhances Lupin's credibility with global ESG-focused investors and strengthens its competitive positioning in the pharmaceutical industry. It signals strong governance and responsible business practices, which could attract long-term institutional investment.